Walleye Capital’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$749K Buy
91,800
+84,600
+1,175% +$1.26M ﹤0.01% 3732
2026
Q2
$171K Buy
7,200
+4,000
+125% +$76.8K ﹤0.01% 3593
2026
Q1
$56.4K Sell
3,200
-3,500
-52% -$70.3K ﹤0.01% 3869
2025
Q4
$132K Sell
6,700
-1,500
-18% -$26.9K ﹤0.01% 3747
2025
Q3
$143K Buy
8,200
+3,800
+86% +$56.3K ﹤0.01% 3522
2025
Q2
$61.6K Buy
4,400
+100
+2% +$1.61K ﹤0.01% 3968
2025
Q1
$80.1K Buy
+4,300
New +$64.1K ﹤0.01% 3701

Other funds holding ALHC

Walleye Capital's ALHC Position: Q3 2026 in Review

Walleye Capital increased its Alignment Healthcare (ALHC) stake by 30% in Q3 2026, buying an estimated $137K and bringing the position to 39,906 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #4434.

Walleye Capital first reported a position in ALHC in Q4 2022 and has held it in 11 quarters since. The position peaked at $3.74M in Q1 2025. 322 funds tracked by Wall St. Rank hold ALHC as of Q3 2026.

  • Walleye Capital held 39,906 shares of Alignment Healthcare worth $326K as of Q3 2026.
  • Walleye Capital bought 9,153 Alignment Healthcare shares in Q3 2026, an estimated $137K.
  • Alignment Healthcare made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #4434 holding.
  • Walleye Capital first reported a position in Alignment Healthcare in Q4 2022 and has held it in 11 quarters since.
  • Walleye Capital's Alignment Healthcare position peaked at $3.74M in Q1 2025.
  • 322 funds tracked by Wall St. Rank held Alignment Healthcare as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.